KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Raw Materials (2016 - 2025)

Pacific Biosciences Of California has reported Raw Materials over the past 15 years, most recently at $38.6 million for Q4 2025.

  • Quarterly results put Raw Materials at $38.6 million for Q4 2025, down 14.65% from a year ago — trailing twelve months through Dec 2025 was $38.6 million (down 14.65% YoY), and the annual figure for FY2025 was $38.6 million, down 14.65%.
  • Raw Materials for Q4 2025 was $38.6 million at Pacific Biosciences Of California, down from $41.8 million in the prior quarter.
  • Over the last five years, Raw Materials for PACB hit a ceiling of $46.0 million in Q2 2025 and a floor of $4.5 million in Q1 2021.
  • Median Raw Materials over the past 5 years was $25.2 million (2023), compared with a mean of $26.1 million.
  • Biggest five-year swings in Raw Materials: skyrocketed 202.0% in 2022 and later dropped 14.65% in 2025.
  • Pacific Biosciences Of California's Raw Materials stood at $8.0 million in 2021, then skyrocketed by 202.0% to $24.1 million in 2022, then soared by 34.36% to $32.4 million in 2023, then skyrocketed by 39.58% to $45.3 million in 2024, then dropped by 14.65% to $38.6 million in 2025.
  • The last three reported values for Raw Materials were $38.6 million (Q4 2025), $41.8 million (Q3 2025), and $46.0 million (Q2 2025) per Business Quant data.